Hostname: page-component-7c8c6479df-94d59 Total loading time: 0 Render date: 2024-03-29T06:15:21.343Z Has data issue: false hasContentIssue false

Aldosterone Production Rates in Manic-Depressive Psychosis

Published online by Cambridge University Press:  29 January 2018

M. N. E. Allsopp
Affiliation:
Division of Steroid Endocrinology, Department of Chemical Pathology, School of Medicine, Leeds, 2
M. J. Levell
Affiliation:
Division of Steroid Endocrinology, Department of Chemical Pathology, School of Medicine, Leeds, 2
S. R. Stitch
Affiliation:
Division of Steroid Endocrinology, Department of Chemical Pathology, School of Medicine, Leeds, 2
R. P. Hullin
Affiliation:
Department of Biochemistry, School of Medicine, Leeds, 2

Extract

In 1963 Coppen and Shaw reported that patients with manic-depressive psychosis showed, on clinical recovery, a significant decrease in exchangeable sodium, and in residual sodium (exchangeable minus extracellular sodium), presumed intracellular, per litre of body water. Coppen, Shaw, Malleson and Costain (1966) found a similar type of shift in mania but the deviation from normal was, on average, more extreme. Although low and high sodium diets had no effects on the distribution of sodium in manic-depressive psychotics, the administration of spironolactone resulted in a significant reduction of residual sodium (Coppen, 1970). The possible involvement of aldosterone in these changes led Jenner et al. (1967) to examine aldosterone excretion in a 48-hour cycle patient and Murphy, Goodwin and Bunney (1969) to examine groups of manic and depressed patients. Murphy et al. found lower rates of excretion of aldosterone in depression than in mania, but Jenner et al. found the opposite.

Type
Papers
Copyright
Copyright © Royal College of Psychiatrists, 1972 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Balikian, H. M., Brodie, A. H., Dale, S. L., Melby, J. C., and Tait, J. F. (1968). ‘Effect of posture on the metabolic clearance rate, plasma concentration and blood production rate of aldosterone in man.’ J. Clin. Endocr., 28, 1630–40.Google Scholar
Brown, D. G., Hullin, R. P., and Roberts, J. M. (1963). ‘Fluid distribution and the response of depression to E.G.T. and imipramine.’ Brit. J. Psychiat., 109, 395–8.Google Scholar
Coppen, A. (1970). Scient. Basis of Medicine Ann. Rev., pp. 189310.Google Scholar
Coppen, A. and Shaw, D. M. (1963). ‘Mineral metabolism in melancholia.’ Brit. med. J., ii, 1439–44.Google Scholar
Coppen, A. and Shaw, D. M. Malleson, A., and Costain, R. (1966). ‘Mineral metabolism in mania.’ Ibid., i, 71–5.Google Scholar
Flood, C., Layne, D. S., Ramcharan, S., Rossipal, E., Tait, J. F., and Tait, S. A. S. (1961). ‘An investigation of the urinary metabolites and secretion rates of aldosterone and cortisol in man and a description of methods for their measurement.’ Acta endocr. (Kbh.), 36, 237–64.Google Scholar
Fraser, R., and James, V. H. T. (1969). Personal communication.Google Scholar
Hullin, R. P., Bailey, A., McDonald, R., Dransfield, G. A., and Milne, H. B. (1967). ‘Body water variations in manic-depressive psychosis.’ Brit, J. Psychiat., 113, 584–92.Google Scholar
Jenner, F., Gjessing, L., Cox, J., Davies-Jones, A., Hullin, R. P., and Hanna, S. (1967). ‘A manic-depressive psychotic with a persistent forty-eight hour cycle.’ Brit. J. Psychiat., 113, 895910.Google Scholar
Moody, J., and Allsopp, M. N. E. (1969). ‘Circadian rhythms of water and electrolyte excretion in manic-depressive psychosis.’ Brit. J. Psychiat., 115, 923–8.CrossRefGoogle ScholarPubMed
Murphy, D., Goodwin, F., and Bunney, W. Jr. (1969). ‘Aldosterone and sodium response to lithium administration in man.’ Lancet, ii, 458–61.Google Scholar
Schou, M. (1957). ‘Biology and pharmacology of the lithium ion.’ Pharmacol. Rev., 9, 1758.Google Scholar
Shahwan, M. M., Oakey, R. E., and Stitch, S. R. (1968). ‘The conversion of pregnenolone to progesterone and 16a-hydroxydehydroepiandrosterone in vitro by adrenal tissue from a newborn anencephalic infant.’ J. endocr., 40, 2935.CrossRefGoogle ScholarPubMed
A synopsis of this paper was published in the December 1971 Journal.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.